GlassScriptPhysician profile
Richard A White
NPI 1770536856
$271.80
in general payments reported to CMS, 2019-2025
11 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.66 · 2020: $46.44 · 2023: $93.23 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $73.41 | 2025 | |
| Dexcom, INC. | $33.59 | 2023 | Dexcom G6 Transmitter |
| Radius Health, INC. | $29.06 | 2025 | Tymlos |
| Stryker Corporation | $27.18 | 2019-2020 | |
| Boston Scientific Corporation | $24.82 | 2023 | Wavewriter Alpha Prime 16 |
| Elite Orthopedics, LLC | $19.48 | 2020 | |
| Zimmer Biomet Holdings, INC. | $19.37 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $16.99 | 2019 | |
| Endo Pharmaceuticals INC. | $15.45 | 2023 | Xiaflex |
| Ethicon US, LLC | $12.45 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$489,450.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.